GALANTAMINE ER DIN 02443023

Status: Marketed

Holder: SANIS HEALTH INC

Molecule: GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Health Canada record

Active ingredient(s)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG
Dosage form	Capsule (Extended-Release)
Route	Oral
Schedule	PRESCRIPTION
Class	Human
ATC	N06DA04 GALANTAMINE
Original market date	11-Jan-2016
Current status date	11-Jan-2016
Source	Health Canada DPD

Establishment licence of the holder

Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GALANTAMINE (GALANTAMINE HYDROBROMIDE)

DIN	Product	Company	Form	Strength	Status
02293021	APO-GALANTAMINE	APOTEX INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Approved
02293048	APO-GALANTAMINE	APOTEX INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02293056	APO-GALANTAMINE	APOTEX INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG	Approved
02425165	AURO-GALANTAMINE ER	AURO PHARMA INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02425173	AURO-GALANTAMINE ER	AURO PHARMA INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02425157	AURO-GALANTAMINE ER	AURO PHARMA INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02316943	GALANTAMINE ER	ESSENTIAL PHARMA SWITZERLAND GMBH	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02316978	GALANTAMINE ER	ESSENTIAL PHARMA SWITZERLAND GMBH	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02316951	GALANTAMINE ER	ESSENTIAL PHARMA SWITZERLAND GMBH	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02562170	GALANTAMINE ER	SIVEM PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02562162	GALANTAMINE ER	SIVEM PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02562154	GALANTAMINE ER	SIVEM PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02443031	GALANTAMINE ER	SANIS HEALTH INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02443015	GALANTAMINE ER	SANIS HEALTH INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02419246	IPG-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Approved
02419254	IPG-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Approved
02419238	IPG-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02570955	MINT-GALANTAMINE ER	MINT PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Approved
02570947	MINT-GALANTAMINE ER	MINT PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Approved
02570939	MINT-GALANTAMINE ER	MINT PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02339455	MYLAN-GALANTAMINE ER	MYLAN PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02339439	MYLAN-GALANTAMINE ER	MYLAN PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02339447	MYLAN-GALANTAMINE ER	MYLAN PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02427273	PENDO-GALANTAMINE ER	PENDOPHARM DIVISION OF PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02333376	PMS-GALANTAMINE	PHARMASCIENCE INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Approved
02333392	PMS-GALANTAMINE	PHARMASCIENCE INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG	Approved
02333384	PMS-GALANTAMINE	PHARMASCIENCE INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02416581	GALANTAMINE ER	PRO DOC LIMITEE	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02416573	GALANTAMINE ER	PRO DOC LIMITEE	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02416603	GALANTAMINE ER	PRO DOC LIMITEE	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02420821	MAR-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02420848	MAR-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02420856	MAR-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02398370	PMS-GALANTAMINE ER	PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02398397	PMS-GALANTAMINE ER	PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02398389	PMS-GALANTAMINE ER	PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02270773	RATIO-GALANTAMINE	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Cancelled Pre Market
02270803	RATIO-GALANTAMINE	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG	Cancelled Pre Market
02270781	RATIO-GALANTAMINE	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Pre Market
02244300	REMINYL -(12MG)	JANSSEN INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG	Cancelled Post Market
02244298	REMINYL -(4MG)	JANSSEN INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Cancelled Post Market
02244299	REMINYL -(8MG)	JANSSEN INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02266717	REMINYL ER	JANSSEN INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02266733	REMINYL ER	JANSSEN INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02266725	REMINYL ER	JANSSEN INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02392305	SANDOZ GALANTAMINE ER	SANDOZ CANADA INCORPORATED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Pre Market
02392283	SANDOZ GALANTAMINE ER	SANDOZ CANADA INCORPORATED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Pre Market
02392291	SANDOZ GALANTAMINE ER	SANDOZ CANADA INCORPORATED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Pre Market
02377977	TEVA-GALANTAMINE ER	TEVA CANADA LIMITED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02377950	TEVA-GALANTAMINE ER	TEVA CANADA LIMITED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02377969	TEVA-GALANTAMINE ER	TEVA CANADA LIMITED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market

Notices of Compliance

NOC	Date	Submission	Reason
17645	2016-01-07	Abbreviated New Drug Submission (ANDS)	LICENSING AGREEMENT BETWEEN TWO COMPANIES

Request a quote for GALANTAMINE ER

How to read a Canadian DIN record